◀ Back to EPHB2
DNM1 — EPHB2
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Jiménez-Sainz et al., Mol Pharmacol 2003
:
In addition, we find that internalization of CCR2B itself is not necessary for efficient MCP-1 induced activation of ERK, although a
dynamin mutant partially
inhibits ERK stimulation
Holstein et al., J Biol Chem 2004
(MAP Kinase Signaling System) :
Neither dominant negative
dynamin ( K44A ) nor dominant negative beta-arrestin
inhibited ERK1/2 activation by either CaR agonist treatment, suggesting that CaR elicited ERK1/2 signaling occurs via a dynamin independent pathway
Gorska et al., J Biol Chem 2006
:
Inhibition of
dynamin by a dominant negative mutant or by small interfering RNA
results in enhancement of IL-5 stimulated
ERK1/2 signaling and cell proliferation
Zheng et al., J Biol Chem 2008
:
In this study, we report that blocking clathrin,
dynamin , or AP2 in cultured neurons of the central nervous system
inhibited brain derived neurotrophic factor (BDNF) induced activation of Akt but not
ERK
Yuen et al., J Biol Chem 2008
:
Inhibition of the
beta-arrestin/Src/dynamin signaling
blocked 5-HT ( 2A/C ) activation of
ERK and the counteractive effect of 5-HT ( 2A/C ) on 5-HT(1A) regulation of NMDAR currents
Ceresa et al., Mol Cell Biol 1998
:
In contrast, expression of
K44A/dynamin partially
inhibited insulin stimulated Shc tyrosine phosphorylation and activation of the mitogen activated protein kinases
ERK1 and -2